Quick Answer
Insight Molecular Diagnostics Inc. reported Net Income Loss of -$50.22 million for the year ending 2025.
- Insight Molecular Diagnostics Inc. showed an increase of +17.2% in Net Income Loss from 2024 to 2025.
- This data is from Insight Molecular Diagnostics Inc.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2014 to 2025 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 12 years of available data (2014 to 2025), Insight Molecular Diagnostics Inc.'s Net Income Loss has declined by 907.3%.
- Historical annual values: Fiscal year 2025: -$50.22 million | Fiscal year 2024: -$60.66 million | Fiscal year 2023: -$27.78 million | Fiscal year 2022: -$72.90 million | Fiscal year 2021: -$64.10 million | Fiscal year 2020: -$29.93 million | Fiscal year 2019: -$22.43 million | Fiscal year 2018: -$15.75 million | Fiscal year 2017: -$19.38 million | Fiscal year 2016: -$11.17 million | Fiscal year 2015: -$8.74 million | Fiscal year 2014: -$4.99 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: